Early oncological outcomes of delayed radical prostatectomy: A prospective, international, follow-up analysis of the COVIDSurg-Cancer study

IF 1.6 Q3 UROLOGY & NEPHROLOGY BJUI compass Pub Date : 2024-10-17 DOI:10.1002/bco2.433
Arjun Nathan, Chuanyu Gao, Alexander Light, Cameron Alexander, Vinson Chan, Kevin Gallagher, Sinan Khadhouri, Kevin G. Byrnes, Michael Ng, Michael Walters, Terry Hughes, Rita J. Perry, Kelvin Okoth, Laura Magill, Thomas Pinkney, Yuhao Zhang, James Blackmur, Eric Etchill, Stanley Tang, Damián García Escudero, Alan McNeill, Krishna Narahari, Grant D. Stewart, Veeru Kasivisvanathan, COVIDSurg Collaborative
{"title":"Early oncological outcomes of delayed radical prostatectomy: A prospective, international, follow-up analysis of the COVIDSurg-Cancer study","authors":"Arjun Nathan,&nbsp;Chuanyu Gao,&nbsp;Alexander Light,&nbsp;Cameron Alexander,&nbsp;Vinson Chan,&nbsp;Kevin Gallagher,&nbsp;Sinan Khadhouri,&nbsp;Kevin G. Byrnes,&nbsp;Michael Ng,&nbsp;Michael Walters,&nbsp;Terry Hughes,&nbsp;Rita J. Perry,&nbsp;Kelvin Okoth,&nbsp;Laura Magill,&nbsp;Thomas Pinkney,&nbsp;Yuhao Zhang,&nbsp;James Blackmur,&nbsp;Eric Etchill,&nbsp;Stanley Tang,&nbsp;Damián García Escudero,&nbsp;Alan McNeill,&nbsp;Krishna Narahari,&nbsp;Grant D. Stewart,&nbsp;Veeru Kasivisvanathan,&nbsp;COVIDSurg Collaborative","doi":"10.1002/bco2.433","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objectives</h3>\n \n <p>The objective of this study is to compare the early oncological outcomes of delayed (&gt;90 days) versus scheduled (≤90 days) radical prostatectomy (RP).</p>\n </section>\n \n <section>\n \n <h3> Patients and methods</h3>\n \n <p>Patients with prostate cancer due to undergo surgery between March 2020 and June 2020 who were enrolled in the COVIDSurg-Cancer international, observational study were prospectively followed up for 1 year. Time to surgery was defined as the difference between the operation date and the multi-disciplinary team decision to offer surgery. The primary outcome was the positive surgical margin (PSM) rate. Biochemical recurrence (BCR), upgradation and upstaging were secondary oncological outcomes. The Independent <i>t</i>-test and Mann Whitney <i>U</i> test were used to compare means between groups and regression models and were used to investigate factors associated with the primary outcome.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Four hundred seventy-six (78.7%) patients underwent RP from 605 that were eligible. Three hundred seven (64.5%) patients underwent scheduled RP, and 169 (35.5%) underwent delayed RP. A small proportion of men (<i>n</i> = 35, 6.8%) did not undergo RP within the 1-year follow-up period. More men with high-risk disease (72.8%) underwent scheduled RP compared to men with intermediate-risk disease (60.2%) (<i>p</i> &lt; 0.05). There was no statistically significant difference in the PSM rate between the two groups (<i>p</i> = 0.512). Delay in surgery was not associated with an increased PSM or BCR on univariable or multivariable analyses. There was statistically significantly greater upstaging (<i>p</i> &lt; 0.05) in the delayed group but no difference in upgradation.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>High-risk men were prioritised for surgery during the COVID-19 pandemic. Our prospective data support previous retrospective, cancer-registry evidence suggesting no adverse oncological impact after delaying RP across all risk groups. Our study is limited by the short follow-up period, and therefore, longer term conclusions cannot be drawn.</p>\n </section>\n </div>","PeriodicalId":72420,"journal":{"name":"BJUI compass","volume":"5 12","pages":"1314-1323"},"PeriodicalIF":1.6000,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11685180/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJUI compass","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/bco2.433","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

The objective of this study is to compare the early oncological outcomes of delayed (>90 days) versus scheduled (≤90 days) radical prostatectomy (RP).

Patients and methods

Patients with prostate cancer due to undergo surgery between March 2020 and June 2020 who were enrolled in the COVIDSurg-Cancer international, observational study were prospectively followed up for 1 year. Time to surgery was defined as the difference between the operation date and the multi-disciplinary team decision to offer surgery. The primary outcome was the positive surgical margin (PSM) rate. Biochemical recurrence (BCR), upgradation and upstaging were secondary oncological outcomes. The Independent t-test and Mann Whitney U test were used to compare means between groups and regression models and were used to investigate factors associated with the primary outcome.

Results

Four hundred seventy-six (78.7%) patients underwent RP from 605 that were eligible. Three hundred seven (64.5%) patients underwent scheduled RP, and 169 (35.5%) underwent delayed RP. A small proportion of men (n = 35, 6.8%) did not undergo RP within the 1-year follow-up period. More men with high-risk disease (72.8%) underwent scheduled RP compared to men with intermediate-risk disease (60.2%) (p < 0.05). There was no statistically significant difference in the PSM rate between the two groups (p = 0.512). Delay in surgery was not associated with an increased PSM or BCR on univariable or multivariable analyses. There was statistically significantly greater upstaging (p < 0.05) in the delayed group but no difference in upgradation.

Conclusion

High-risk men were prioritised for surgery during the COVID-19 pandemic. Our prospective data support previous retrospective, cancer-registry evidence suggesting no adverse oncological impact after delaying RP across all risk groups. Our study is limited by the short follow-up period, and therefore, longer term conclusions cannot be drawn.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
延迟根治性前列腺切除术的早期肿瘤预后:一项前瞻性,国际,covid -外科-癌症研究的随访分析。
目的:本研究的目的是比较延迟(≤90天)和计划(≤90天)根治性前列腺切除术(RP)的早期肿瘤预后。患者和方法:纳入covid - surgical - cancer国际观察性研究的2020年3月至2020年6月期间接受手术的前列腺癌患者,前瞻性随访1年。手术时间定义为手术日期与多学科团队决定提供手术之间的差异。主要结果为手术切缘阳性(PSM)率。生化复发(BCR)、升级和上位是次要的肿瘤预后。使用独立t检验和Mann Whitney U检验比较组间均值和回归模型,并用于调查与主要结局相关的因素。结果:605例患者中有476例(78.7%)接受了RP。397例(64.5%)患者接受了预定RP, 169例(35.5%)患者接受了延迟RP。一小部分男性(n = 35, 6.8%)在1年随访期间未接受RP。与中危男性(60.2%)相比,高危男性(72.8%)接受了计划RP (p = 0.512)。单变量或多变量分析显示,延迟手术与PSM或BCR的增加无关。结论:在COVID-19大流行期间,高危男性优先接受手术治疗。我们的前瞻性数据支持之前的回顾性癌症登记证据,表明在所有风险组中延迟RP后没有不良的肿瘤影响。本研究受限于随访时间较短,因此无法得出较长期的结论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.30
自引率
0.00%
发文量
0
审稿时长
12 weeks
期刊最新文献
The impact of biopsy core length on the discrepancy in Gleason scores between biopsy and radical prostatectomy specimen Flexible cystoscopy-guided implantation of ProACT: Surgical technique and long-term outcomes Preoperative pelvic floor muscle diameter as a predictor of postoperative urinary incontinence in robotic-assisted laparoscopic total prostatectomy Issue Information Long-term outcomes of cutaneous ureterostomy with the aim of stent-free stoma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1